Efficacy of intra-hepatectomy 5-FU on recurrence and metastasis of human hepatocellular carcinoma in nude mice

International Journal of Cancer

Volumn 91, Issue 2, 2001, Pages 231-235

  Rashidi, Babak ^a   An, Zili ^b   Sun, Fang Xian ^b   Li, Xiaoming ^c   Tang, Z Y ^b   Moossa, A R ^c   Hoffman, Robert M ^a  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

Chemotherapy; Hepatocellular carcinoma; Intra hepatectomy 5 Fu; Mice

Indexed keywords

FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHEMOSURGERY; CONTROLLED STUDY; FEMALE; INTRAOPERATIVE PERIOD; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; NUDE MOUSE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0035863582     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1042>3.3.CO;2-O     Document Type: Article

References (41)

1. Treatment of hepatocellular carcinoma associated with cirrhosis in era of liver transplantation
2. Hepatocellular carcinoma
3. Liver transplantation for malignant disease
4. Prognostic factors for survival in hepatocellular carcinoma
5. Liver transplantation for primary hepatocellular carcinoma: Tumor size and number determine outcome
6. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver
7. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
8. The role of liver transplantation in hepatobiliary malignancy
9. Hepatic resection versus transplantation for hepatocellular carcinoma
10. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
11. Vascularization of small hepatocellular carcinomas: Correlation with differentiation
12. Intrahepatic recurrence after curative resection of hepatocellular carcinoma. Long-term results of treatment and prognostic factors
13. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma
14. Promotion of hepatic metastases by liver resection in the rat
15. Minimal liver resection strongly stimulates the growth of human colon cancer in the liver of nude mice
16. Anti-metastatic intra-operative chemotherapy of human colon rumors in the liver of nude mice
17. Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: A prospective randomized study
18. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: A randomized controlled trial
19. Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma?
20. Assessment of patients and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma
21. Improved survival of hepatocellular cancer with combination surgery and multimodality treatment
22. Chemoembolization of hepatocellular carcinoma: Results of a metaanalysis
23. Intra-arterial chemoembolization in patients with hepatocellular carcinoma
24. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens
25. A metastatic nude mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens
26. Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: Benefits of fragment implantation compared to cell-suspension injection
27. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic
28. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues
29. Do the tumor cells of hepatocellular carcinomas dislodge into portal venous stream during hepatic resection?
30. Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling
31. Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcatheter arterial embolization
32. Phase I pharmacological studies of 5-fluorouracil administrated intraperitoneally
33. Portal levels and hepatic clearance of 5-fluorouracil after intraperituneal administration in humans
34. Pharmacology of intraperitoneal infusion of 5-fluorouracil and mitomycin-C
35. The route of absorption of intraperitoneally administrated compounds
36. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer
37. Adjuvant portal liver infusion with 5-fluorouracil and mitomycin in colorectal cancer
38. Adjuvant therapy of Dukes' A, B and C adenocarcinoma of the colon with portal vein fluorouracil hepatic infusion: Preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02
39. Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration
40. 5-FU uptake in liver metastases after intravenous and intraperitoneal administration: An autoradiographic study in the rat
41. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy